Basics Avanos Medical, Inc. IPO Date: October 20, 2014 Sector: Healthcare Industry: Biotech Market Cap: $545.89M Activated in VL: True Average Daily Range Avg Daily Range: $0.48 | 1.61% Avg Daily Range (30 D): $0.22 | 1.91% Avg Daily Range (90 D): $0.22 | 1.90% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .45M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 57 Institutional Trades Total Inst.Trades: 2,670 Avg Inst. Trade: $1.56M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $1.36M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 55.81K     News Aug 5, 2025 @ 2:14 PM Avanos (AVNS) Q2 2025 Earnings Call Transcript Source: The Motley Fool Dec 30, 2024 @ 12:58 PM United States Syringes, Needles and Urinary Cathet... Source: Researchandmarkets.Com Oct 6, 2024 @ 11:30 PM Bio Pharma Buffer Market to Reach $2.4 Billion, Gl... Source: Allied Market Research Aug 29, 2024 @ 12:17 PM Pain Management Devices Market to Witness 21.5 % C... Source: Globe Newswire Aug 5, 2024 @ 11:52 AM Is Phibro (PAHC) Stock Worth Retaining in Your Por... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-10.19 $-.03 $-1.66 Diluted EPS $-10.19 $-.03 $-1.66 Revenue $ 699.9M $ 177.8M $ 175M Gross Profit $ 365.9M $ 86M $ 92.1M Net Income / Loss $ -468.9M $ -1.4M $ -76.8M Operating Income / Loss $ -482.6M $ .1M $ -74.5M Cost of Revenue $ 334M $ 91.8M $ 82.9M Net Cash Flow $ -18.5M $ -19.8M $ -6.7M PE Ratio     Splits May 15, 2006:   1:100